Literature DB >> 25382994

Discussing the need for an adolescent hepatitis B vaccine booster in infant vaccinees.

Michelle Pinto1, David Scheifele2.   

Abstract

Entities:  

Year:  2014        PMID： 25382994      PMCID： PMC4220521          DOI： 10.1093/pch/19.8.404

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN： 1205-7088            Impact factor:   2.253


× No keyword cloud information.
  5 in total

1.  Antibody persistence and the effect of a booster dose given 5, 10 or 15 years after vaccinating preadolescents with a recombinant hepatitis B vaccine.

Authors:  Vladimir Gilca; Gaston De Serres; Nicole Boulianne; Donald Murphy; Philippe De Wals; Manale Ouakki; Gisele Trudeau; Richard Massé; Marc Dionne
Journal:  Vaccine       Date:  2012-12-01       Impact factor: 3.641

Review 2.  Determinants of Long-term protection after hepatitis B vaccination in infancy: a meta-analysis.

Authors:  Katharina Schönberger; Christina Riedel; Simon Rückinger; Ulrich Mansmann; Wolfgang Jilg; Rüdiger V Kries
Journal:  Pediatr Infect Dis J       Date:  2013-04       Impact factor: 2.129

3.  Assessment of a universal, school-based hepatitis B vaccination program.

Authors:  S Dobson; D Scheifele; A Bell
Journal:  JAMA       Date:  1995-10-18       Impact factor: 56.272

4.  Hepatitis B vaccination: a completed schedule enough to control HBV lifelong? Milan, Italy, 17-18 November 2011.

Authors:  David FitzSimons; Greet Hendrickx; Alex Vorsters; Pierre Van Damme
Journal:  Vaccine       Date:  2012-11-08       Impact factor: 3.641

5.  Observational study of vaccine efficacy 14 years after trial of hepatitis B vaccination in Gambian children.

Authors:  Hilton Whittle; Shabbar Jaffar; Michael Wansbrough; Maimuna Mendy; Uga Dumpis; Andrew Collinson; Andrew Hall
Journal:  BMJ       Date:  2002-09-14
  5 in total
  1 in total

1.  From infancy and beyond… ensuring a lifetime of hepatitis B virus (HBV) vaccine-induced immunity.

Authors:  Carla Osiowy
Journal:  Hum Vaccin Immunother       Date:  2018-05-18       Impact factor: 3.452
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.